{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:10:35Z","timestamp":1792440635682,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014943","name":"Sarepta Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014943","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.nmd.2023.03.008","type":"journal-article","created":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T21:59:50Z","timestamp":1679608790000},"page":"476-483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Safety, tolerability and pharmacokinetics of eteplirsen in young boys aged 6\u201348 months with Duchenne muscular dystrophy amenable to exon 51 skipping"],"prefix":"10.1016","volume":"33","author":[{"given":"E.","family":"Mercuri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Seferian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Servais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Deconinck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"East","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Yonren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Muntoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Deconinck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudy","family":"Van Coster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Vanlander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea","family":"Seferian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"De Lucia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Gidaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Vanden","family":"Brande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Servais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janbernd","family":"Kirschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Borell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Mercuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Brogna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Pane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavinia","family":"Fanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Norcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Muntoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Brusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Chesshyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Maresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaqueline","family":"Pitchforth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Schottlaender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariacristina","family":"Scoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpana","family":"Silwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fedrica","family":"Trucco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2023.03.008_bib0001","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1474-4422(18)30024-3","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2023.03.008_bib0002","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: the protein product of the Duchenne muscular dystrophy locus","volume":"51","author":"Hoffman","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.nmd.2023.03.008_bib0003","first-page":"184","article-title":"The role of fibrosis in Duchenne muscular dystrophy","volume":"31","author":"Klingler","year":"2012","journal-title":"Acta Myol"},{"key":"10.1016\/j.nmd.2023.03.008_bib0004","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jpeds.2009.02.007","article-title":"Delayed diagnosis in duchenne muscular dystrophy: data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet)","volume":"155","author":"Ciafaloni","year":"2009","journal-title":"J Pediatr"},{"key":"10.1016\/j.nmd.2023.03.008_bib0005","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/dmcn.14623","article-title":"Early developmental milestones in Duchenne muscular dystrophy","volume":"62","author":"van Dommelen","year":"2020","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.nmd.2023.03.008_bib0006","article-title":"Correction: long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53","volume":"14","author":"Brogna","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nmd.2023.03.008_bib0007","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.nmd.2019.09.010","article-title":"Longitudinal natural history in young boys with Duchenne muscular dystrophy","volume":"29","author":"Coratti","year":"2019","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2023.03.008_bib0008","doi-asserted-by":"crossref","first-page":"e52512","DOI":"10.1371\/journal.pone.0052512","article-title":"24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy","volume":"8","author":"Mazzone","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nmd.2023.03.008_bib0009","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3233\/JND-200548","article-title":"Comparison of long-term ambulatory function in patients with Duchenne muscular dystrophy treated with eteplirsen and matched natural history controls","volume":"8","author":"Mendell","year":"2021","journal-title":"J Neuromuscul Dis"},{"issue":"2","key":"10.1016\/j.nmd.2023.03.008_bib0010","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/mus.27532","article-title":"Time to diagnosis of Duchenne Muscular Dystrophy remains unchanged: findings from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet), 2000-2015","volume":"66","author":"Thomas","year":"2022","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2023.03.008_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253882","article-title":"North Star Ambulatory Assessment changes in ambulant Duchenne boys amenable to skip exons 44, 45, 51, and 53: a 3 year follow up","volume":"16","author":"Coratti","year":"2021","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nmd.2023.03.008_bib0012","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/mus.27427","article-title":"Genotype-related respiratory progression in Duchenne muscular dystrophy-A multicenter international study","volume":"65","author":"Trucco","year":"2022","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2023.03.008_bib0013","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1038\/s41598-021-82725-z","article-title":"Newborn screening of duchenne muscular dystrophy specifically targeting deletions amenable to exon-skipping therapy","volume":"11","author":"Beckers","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.nmd.2023.03.008_bib0014","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12519-019-00242-6","article-title":"Progress in treatment and newborn screening for Duchenne muscular dystrophy and spinal muscular atrophy","volume":"15","author":"Ke","year":"2019","journal-title":"World J Pediatr"},{"key":"10.1016\/j.nmd.2023.03.008_bib0015","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/mus.25185","article-title":"Clinical follow-up for Duchenne muscular dystrophy newborn screening: a proposal","volume":"54","author":"Kwon","year":"2016","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2023.03.008_bib0016","doi-asserted-by":"crossref","first-page":"e2270","DOI":"10.1212\/WNL.0000000000009233","article-title":"Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy","volume":"94","author":"Frank","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2023.03.008_bib0017","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nrd3625","article-title":"RNA therapeutics: beyond RNA interference and antisense oligonucleotides","volume":"11","author":"Kole","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.nmd.2023.03.008_bib0018","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/mt.2008.287","article-title":"Design of phosphorodiamidate morpholino oligomers (PMOs) for the induction of exon skipping of the human DMD gene","volume":"17","author":"Popplewell","year":"2009","journal-title":"Mol Ther"},{"key":"10.1016\/j.nmd.2023.03.008_bib0019","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3233\/JND-210643","article-title":"Open-label evaluation of eteplirsen in patients with Duchenne muscular dystrophy amenable to exon 51 skipping: PROMOVI Trial","volume":"8","author":"McDonald","year":"2021","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2023.03.008_bib0020","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/mus.27347","article-title":"Safety, tolerability, and pharmacokinetics of casimersen in patients with Duchenne muscular dystrophy amenable to exon 45 skipping: a randomized, double-blind, placebo-controlled, dose-titration trial","volume":"64","author":"Wagner","year":"2021","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2023.03.008_bib0021","series-title":"EXONDYS (eteplirsen) injection, for intravenous use [Prescribing information]","year":"2020"},{"key":"10.1016\/j.nmd.2023.03.008_bib0022","series-title":"EXONDYS (eteplirsen) injection, for intravenous use [Prescribing information]","year":"2022"},{"key":"10.1016\/j.nmd.2023.03.008_bib0023","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(11)60756-3","article-title":"Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study","volume":"378","author":"Cirak","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.nmd.2023.03.008_bib0024","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/mus.27662","article-title":"Delays in pulmonary decline in eteplirsen-treated patients with Duchenne muscular dystrophy","volume":"66","author":"Iff","year":"2022","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2023.03.008_bib0025","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/ana.24555","article-title":"Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy","volume":"79","author":"Mendell","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2023.03.008_bib0026","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/ana.23982","article-title":"Eteplirsen for the treatment of Duchenne muscular dystrophy","volume":"74","author":"Mendell","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2023.03.008_bib0027","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3233\/JND-210665","article-title":"A combined prospective and retrospective comparison of long-term functional outcomes suggests delayed loss of ambulation and pulmonary decline with long-term eteplirsen treatment","volume":"9","author":"Mitelman","year":"2022","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2023.03.008_bib0028","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1542\/peds.111.6.1416","article-title":"National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification","volume":"111","author":"Hogg","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.nmd.2023.03.008_bib0029","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0022-3476(82)80287-4","article-title":"Isolated proteinuria: analysis of a school-age population","volume":"101","author":"Vehaskari","year":"1982","journal-title":"J Pediatr"},{"key":"10.1016\/j.nmd.2023.03.008_bib0030","series-title":"Tolerability of eteplirsen for duchenne muscular dystrophy in the youngest reported patient treated with this therapy","author":"Bhalla S","year":"2018"},{"key":"10.1016\/j.nmd.2023.03.008_bib0031","doi-asserted-by":"crossref","first-page":"e15858","DOI":"10.1097\/MD.0000000000015858","article-title":"Long-term treatment with eteplirsen in nonambulatory patients with Duchenne muscular dystrophy","volume":"98","author":"Alfano","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.nmd.2023.03.008_bib0032","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1053\/j.ackd.2020.02.005","article-title":"Challenges of vascular access in the pediatric population","volume":"27","author":"Raina","year":"2020","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.nmd.2023.03.008_bib0033","doi-asserted-by":"crossref","first-page":"350","DOI":"10.2174\/1574884709666140520153308","article-title":"Pharmacokinetic studies in infants using minimal-risk study designs","volume":"9","author":"Autmizguine","year":"2014","journal-title":"Curr Clin Pharmacol"},{"key":"10.1016\/j.nmd.2023.03.008_bib0034","series-title":"Presented at American Conference on Pharmacometrics","article-title":"Model-informed eteplirsen dosing regimen extension across age range for the DMD population","author":"Patel","year":"2022"},{"key":"10.1016\/j.nmd.2023.03.008_bib0035","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pediatrneurol.2020.08.013","article-title":"Natural history of steroid-treated young boys with Duchenne muscular dystrophy using the NSAA, 100m, and timed functional tests","volume":"113","author":"Miller","year":"2020","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.nmd.2023.03.008_bib0036","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejpn.2020.06.001","article-title":"Qualitative and quantitative muscle ultrasound in patients with Duchenne muscular dystrophy: here do sonographic changes begin?","volume":"28","author":"Vill","year":"2020","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.nmd.2023.03.008_bib0037","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.pedneo.2013.03.009","article-title":"Pompe disease: early diagnosis and early treatment make a difference","volume":"54","author":"Chien","year":"2013","journal-title":"Pediatr Neonatol"},{"key":"10.1016\/j.nmd.2023.03.008_bib0038","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.nmd.2019.09.007","article-title":"Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: interim efficacy and safety results from the Phase 2 NURTURE study","volume":"29","author":"De Vivo","year":"2019","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2023.03.008_bib0039","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1474-4422(21)00367-7","article-title":"Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial","volume":"21","author":"Mercuri","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2023.03.008_bib0040","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/s41591-022-01867-3","article-title":"Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the Phase III SPR1NT trial","volume":"28","author":"Strauss","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.nmd.2023.03.008_bib0041","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/s41591-022-01889-x","article-title":"Early treatment is a lifeline for infants with SMA","volume":"28","author":"Sumner","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.nmd.2023.03.008_bib0042","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1136\/jnnp.35.4.451","article-title":"Structural changes in the early stages of Duchenne muscular dystrophy","volume":"35","author":"Bradley","year":"1972","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2023.03.008_bib0043","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1212\/01.wnl.0000173836.09176.c4","article-title":"Early onset of inflammation and later involvement of TGFbeta in Duchenne muscular dystrophy","volume":"65","author":"Chen","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2023.03.008_bib0044","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1136\/archdischild-2014-306366","article-title":"Improving recognition of Duchenne muscular dystrophy: a retrospective case note review","volume":"99","author":"van Ruiten","year":"2014","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.nmd.2023.03.008_bib0045","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/ppul.21254","article-title":"The respiratory management of patients with duchenne muscular dystrophy: a DMD care considerations working group specialty article","volume":"45","author":"Birnkrant","year":"2010","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.nmd.2023.03.008_bib0046","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014004","article-title":"Cardiac intervention improves heart disease and clinical outcomes in patients with muscular dystrophy in a multidisciplinary care setting","volume":"9","author":"Nikhanj","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.nmd.2023.03.008_bib0047","first-page":"121","article-title":"Improvement of survival in Duchenne Muscular Dystrophy: retrospective analysis of 835 patients","volume":"31","author":"Passamano","year":"2012","journal-title":"Acta Myol"},{"key":"10.1016\/j.nmd.2023.03.008_bib0048","doi-asserted-by":"crossref","DOI":"10.1002\/ajmg.c.31993","article-title":"Duchenne expert physician perspectives on Duchenne newborn screening and early Duchenne care","author":"Armstrong","year":"2022","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.nmd.2023.03.008_bib0049","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1007\/s10072-022-06128-2","article-title":"Duchenne muscular dystrophy newborn screening: the first 50,000 newborns screened in Taiwan","volume":"43","author":"Chien","year":"2022","journal-title":"Neurol Sci"},{"key":"10.1016\/j.nmd.2023.03.008_bib0050","unstructured":"https:\/\/www.parentprojectmd.org\/ppmd-submits-rusp-nomination-package-for-duchenne-muscular-dystrophy\/ Access date April 24, 2023."},{"key":"10.1016\/j.nmd.2023.03.008_bib0051","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S0140-6736(17)31611-2","article-title":"Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"390","author":"McDonald","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.nmd.2023.03.008_bib0052","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/mus.24332","article-title":"Ataluren treatment of patients with nonsense mutation dystrophinopathy","volume":"50","author":"Bushby","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2023.03.008_bib0053","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/mus.26441","article-title":"Twice-weekly glucocorticosteroids in infants and young boys with Duchenne muscular dystrophy","volume":"59","author":"Connolly","year":"2019","journal-title":"Muscle Nerve"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896623000743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896623000743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:13:16Z","timestamp":1760775196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896623000743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0960896623000743"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2023.03.008","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety, tolerability and pharmacokinetics of eteplirsen in young boys aged 6\u201348 months with Duchenne muscular dystrophy amenable to exon 51 skipping","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2023.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}